Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 2c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of ($0.02). Revenue for the quarter came in at $18.49 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Burckhardt Compression (BCHN:SW) PT Lowered to CHF620 at Berenberg
• StoneX Starts Hope Bancorp (HOPE) at Hold
• Goldman Sachs Starts MeiraGTx Holdings plc (MGTX) at Neutral